Sign up here for GlobalData's free bi-weekly Covid-19 report on the latest information your industry needs to know.India-based Panacea Biotec has partnered with Refana USA for the development, manufacturing and distribution of a Covid-19 vaccine candidate worldwide.
The partners intend to form a joint venture company to enable equitable global access to the vaccine. The joint venture will be based in Ireland.
Panacea Biotec and Refana will work on a whole inactivated virus-based vaccine against Covid-19. As part of the deal, Panacea Biotec will carry out product development and commercial manufacturing, while the joint venture will be responsible for clinical development and regulatory submissions globally.